In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study
The accumulation of WAT might be responsible for dedifferentiation, making it a potential new target to curb diabetes onset.
Authors
- Ilenia Severi (ORCID: https://orcid.org/0000-0002-3985-1131)
- Saverio Cinti (ORCID: https://orcid.org/0000-0003-0362-5017)
- Umberto Capece (ORCID: https://orcid.org/0000-0001-8048-8664)
- Martina Senzacqua (ORCID: https://orcid.org/0000-0002-8543-6764)
- Giuseppe Quero (ORCID: https://orcid.org/0000-0002-0001-9479)
- Enrico Celestino Nista
- Antonio Gasbarrini (ORCID: https://orcid.org/0000-0002-6230-1779)
- Gea Ciccarelli (ORCID: https://orcid.org/0009-0001-3621-6298)
- Gianfranco Di Giuseppe (ORCID: https://orcid.org/0000-0003-4506-5193)
- Laura Soldovieri (ORCID: https://orcid.org/0009-0001-3315-0406)
- Simona Moffa (ORCID: https://orcid.org/0000-0001-6013-3428)
- Michela Brunetti (ORCID: https://orcid.org/0009-0008-0139-4749)
- Shawn Gugliandolo (ORCID: https://orcid.org/0000-0002-9656-4171)
- Teresa Mezza (ORCID: https://orcid.org/0000-0001-5407-9576)
- Vincenzo Tondolo (ORCID: https://orcid.org/0000-0003-0256-3766)
- Francesca Cinti (ORCID: https://orcid.org/0000-0001-5170-7055)
- Andrea Giaccari (ORCID: https://orcid.org/0000-0002-7462-7792)
- A.W. Avolio (ORCID: https://orcid.org/0000-0003-2491-7625)
- Alfredo Pontecorvi (ORCID: https://orcid.org/0000-0003-0570-6865)
- Rossana Moroni (ORCID: https://orcid.org/0000-0002-3477-6136)
- Cassandra Morciano
- Sergio Alfieri (ORCID: https://orcid.org/0000-0002-8057-0788)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Marche Polytechnic University (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-02-11
- DOI
- https://doi.org/10.1016/j.diabres.2025.112029
- Citations
- 2
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Eli Lilly and Company
- AstraZeneca
- European Foundation for the Study of Diabetes